Ovuclon

Quick links to important sections

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Ovuclon

Quick Facts

Property Description
Active Ingredient Clomiphene citrate
Form Oral Tablet
Pharmacological Class Selective Estrogen Receptor Modulator (SERM)
Common Use Inducing Ovulation
Origin Synthetic, Non-Steroidal

What Type of Medicine is Ovuclon? (Definition and Classification)

Ovuclon is a prescription medication whose active ingredient is Clomiphene citrate, a synthetic, non-steroidal compound. This medicine is a specific brand of Clomiphene, typically supplied as an oral tablet for patient convenience. Ovuclon belongs to the pharmacological class known as Selective Estrogen Receptor Modulators (SERMs), a classification used for medications that influence hormonal function.

Ovuclon is a single-ingredient product characterized by its non-steroidal structure, which concentrates its function on the mechanism of the SERM. As a prescription-only item, Ovuclon is differentiated by its required medical oversight, ensuring appropriate use for its intended therapeutic purpose.

Why is Clomifene Classified as a Fertility Agent? (Purpose and Mechanism Principle)

Clomifene is classified as a Fertility Agent because its primary general purpose is to promote and induce ovulation in women. The medicine works through a high-level mechanism involving hormonal signal adjustment. For instance, in a typical neutral use scenario involving anovulation, the medicine functions by temporarily engaging specific estrogen receptors in the brain's regulatory centers.

This action signals the body to increase its natural output of fertility hormones, Follicle-Stimulating Hormone (FSH) and Luteinizing Hormone (LH). This induced release of gonadotropins is intended to correct ovulatory dysfunction by encouraging the development and subsequent release of a mature egg from the ovary. Its application makes it a widely utilized, foundational therapeutic option for managing fertility challenges.

Regulatory References

  1. as described by NIH/MedlinePlus

What side effects are possible with Ovuclon?

Possible Side Effects and Safety Information

The safety profile of Ovuclon (Clomiphene citrate), as documented in official regulatory labeling, outlines adverse reactions categorized by their frequency and affected body system. Safety information is non-instructional and focuses strictly on officially documented risks.


Adverse Reaction Classification

Side effects are primarily classified into specific System-Organ Classes (SOCs), with the most frequent effects falling under Vascular, Reproductive, and Nervous System disorders.

Classification Examples of Officially Documented Effects
Common Hot flushes, ovarian enlargement, pelvic/abdominal discomfort, nausea, vomiting, headache.
Uncommon Blurred vision, scotomata (spots/flashes), dizziness, depression, insomnia, breast discomfort.
Rare Severe Ovarian Hyperstimulation Syndrome (OHSS), pancreatitis, stroke, seizure.

Serious Safety Considerations

The most clinically significant serious adverse reaction documented is Ovarian Hyperstimulation Syndrome (OHSS), which, while Rare in its severe form, is associated with complications such as pulmonary and vascular compromise. Furthermore, prolonged use of Clomiphene (e.g., for one year or more) is associated with an increased risk of ovarian cancer, and visual disturbances may become irreversible if treatment duration or dosage is excessive.

Ovuclon is strictly contraindicated in specific circumstances. These regulatory limitations include women who are pregnant, individuals with active liver disease or dysfunction, and those with unexplained abnormal uterine bleeding or specific types of ovarian cysts (other than those related to Polycystic Ovary Syndrome).

This information structures the drug's safety profile by classifying risks into frequency bands and highlighting specific duration-dependent constraints and mandatory pre-existing condition exclusions.

Overdose and Emergency Response

Overdose and When to Seek Help

Overdose information for Ovuclon (Clomiphene citrate) is strictly based on official regulatory documentation and centers on specific clinical manifestations and mandated emergency actions.

Documented Manifestations and Severe Risks

An overdose or excessive response may present with signs including nausea, vomiting, hot flushes, and abdominal or pelvic pain related to ovarian enlargement. Regulators specifically document that an increased total dose or duration of therapy may contribute to potentially irreversible visual disturbances, such as blurred vision and the appearance of spots or flashes (scintillating scotomata). A primary, life-threatening risk associated with an excessive response is the potential progression to Severe Ovarian Hyperstimulation Syndrome (OHSS), which requires immediate medical management.

Mandated Emergency Actions

Regulatory guidance requires that treatment must be stopped immediately if visual symptoms or signs of OHSS (such as rapid weight gain, severe abdominal pain, or trouble breathing) are observed. In the event of suspected overdose, appropriate supportive measures should be employed, as it is documented that no specific antidote is known for Clomiphene citrate. Immediate medical help must be sought (e.g., calling emergency services) if an individual has collapsed, has a seizure, or is experiencing difficulty breathing, exactly as instructed in official drug information.

Therapeutic Uses of Ovuclon

Main Uses and Benefits of Ovuclon

This section outlines the primary conditions Ovuclon is commonly used to treat and the key therapeutic benefits it may offer to patients seeking pregnancy.


Therapeutic Focus on Ovulatory Disorders

Ovuclon is commonly used and relevant for managing infertility related to specific systemic imbalances in the reproductive cycle. It is applied across conditions presenting with episodic or fluctuating manifestations, most notably absent or irregular ovulation (anovulation or oligo-ovulation), and ovulatory dysfunction often associated with Polycystic Ovary Syndrome (PCOS). This treatment is used for managing the symptomatic domain of absent or irregular ovulation in women who wish to become pregnant.

This medication helps address symptom clusters that interfere with daily comfort and family planning by supporting the timing of egg release. In this context, it is commonly used when symptoms of ovulatory failure become more noticeable.

“This approach is highly relevant in clinical settings where the primary goal is to address the specific functional strain of irregular or non-existent ovulation.”

Quick Fact: Relief for Ovulatory Infertility The medication assists with maintaining functional stability in the reproductive process, contributing to easing the overall symptom load related to reproductive uncertainty.


Key Patient Benefit: Supporting Conception

The main benefit of Ovuclon is its role in supporting ovulatory function in women who struggle to ovulate naturally. It is a relevant method to address a core reproductive obstacle, which may help patients cope more steadily with the symptom clusters of infertility and may assist with increasing the monthly chance of conception.

Regulatory References

  1. NIH MedlinePlus overview

Eligibility and Restrictions for Use

Ovuclon (Clomiphene citrate) is approved for use only in adult women who desire pregnancy and have documented ovulatory dysfunction, such as anovulation or oligo-ovulation.


Absolute Contraindications

The medicine is contraindicated and must not be used in women who are pregnant or have specific pre-existing conditions. These absolute exclusions include patients with active liver disease or a history of liver dysfunction, undetermined abnormal uterine bleeding, certain ovarian cysts (not due to PCOS), or a known hypersensitivity to Clomiphene citrate. Use is also prohibited for individuals with uncontrolled thyroid or adrenal dysfunction or an organic intracranial lesion.


Conditional and Age Restrictions

Safety and effectiveness are not established for use in pediatric patients, and the medicine is not typically indicated for geriatric use. Regulatory guidelines do not recommend using the medicine for more than a total of six treatment cycles. Caution is required if the patient has uterine fibroids due to the potential for enlargement. For breastfeeding women, use is generally not recommended, as the drug may suppress lactation. Additionally, the medicine must be discontinued immediately if the patient experiences visual symptoms.

What should I know about interactions with other medicines?

Ovuclon (clomiphene citrate) has not been widely reported to have specific or common drug-drug interactions in clinical studies. However, as with any medication, it is important to discuss all prescription and non-prescription medicines, vitamins, and herbal supplements with a healthcare provider before starting treatment.

Potential Interactions

While direct, definitive interactions are rare, the following categories of products should be discussed with your physician:

  • Antidepressants: Ovuclon should be used with caution in patients taking antidepressants, particularly those that may affect serotonin levels, due to the potential for compounded effects. Antidepressants, specifically selective serotonin reuptake inhibitors (SSRIs), have, in some cases, been associated with an increase in serum prolactin levels, which could theoretically influence ovulation induction.
  • Herbal Supplements: Certain dietary or herbal supplements, such as chasteberry, black cohosh, and blue cohosh, are sometimes used for hormonal or fertility support. Because these may possess hormonal or anti-estrogenic activity, combining them with Ovuclon could potentially alter its therapeutic effect. The use of Prasterone is also noted as a potential interaction.
  • Alcohol: Caution is advised when consuming alcoholic drinks during treatment, as this may increase the risk of certain side effects, such as dizziness or fainting spells.

Always ensure your doctor is aware of your complete medical history and all co-administered products to allow for proper monitoring and management of potential risks.

Mechanism of Action

How Ovuclon Works: Pharmacodynamics

Ovuclon functions through the precise modulation of key signaling pathways, resulting in the alteration of downstream pathway activity. Its pharmacodynamic actions are concentrated within specific molecular domains that control hyper-responsive biological processes, thereby defining the resulting physiological adjustments.


Receptor- and Enzyme-Mediated Signaling Modulation

Ovuclon acts within domains involving receptor- or enzyme-mediated signaling to influence early molecular steps that shape systemic physiological outcomes. This mechanism engages regulatory processes that influence overactive or dysregulated components, leading to the reduction of hyperactivity within targeted systems.


Key Pathway Effect and Cascade Regulation

The drug modulates pathways associated with heightened physiological responses by initiating or suppressing signaling sequences that lead to specific downstream effects. This intervention is relevant in cascades where multiple layers of pathway activation occur, facilitating the restoration of feedback mechanisms within pathways and resulting in measurable changes to physiological set points.


Regulation of Specific Transmitter Systems

Ovuclon affects biological systems where specific transmitters or mediators dominate, and is used to alter pathway activity that exhibits sensitivity to these components. This action results in reduced downstream signaling initiated by mediators, supporting the regulation of processes driven by distinct signaling patterns.

Dosage and Administration Information

How to Use Ovuclon: Administration Guidelines

Ovuclon, which contains the active ingredient Clomiphene citrate, is administered as an oral tablet according to a cyclical schedule. The usage protocol is designed to align with the body’s reproductive cycle, focusing strictly on specific timing and dosage parameters.


Administration Scope

Feature Guideline Description
Route of Administration Oral (by mouth), as a tablet form.
Standard Dosing Regimen The initial course is typically 50 mg administered once daily for five consecutive days. If required, the dose may be increased to 100 mg daily for five days, but the dose should not exceed 100 mg per day.
Cycle Timing Administration is initiated on or about the fifth day of the menstrual cycle. If bleeding is absent, the course may begin at any time.
Preparation No preparation is required; it is administered as an intact oral tablet.

Procedural Structure and Limits

Ovuclon is intended for use over a finite period. Treatment is generally limited to a maximum of approximately six treatment cycles in total. The standard use protocol includes a pelvic examination before the first course and before each subsequent course of treatment to ensure proper administration conditions are met. Special consideration for using a lower dosage or shorter duration may be given to patients with conditions like Polycystic Ovary Syndrome (PCOS).

Recent Clinical Evidence

Research Evidence / Overview of Studies for Ovuclon

Evidence for use in Predicting Peak Fertility (Ovulation)

Research has explored studies of Ovuclon related to the prediction of peak fertility (ovulation). Studies for this investigation primarily use observational and comparative methods, where the device's measurements was evaluated in relation to established methods like ultrasound or hormone level testing. This work was studied for how frequently the device may indicate the most fertile window within a woman's cycle.

The findings from these studies contribute to understanding patterns observed during short-term usage periods. Research highlights changes measured during the study period, and studies monitored data in relation to the approaching ovulation phase.

However, certain aspects remain uncertain. Specifically, the evidence for Ovuclon’s application in conditions characterized by fluctuating or episodic manifestations—such as very irregular cycles—is limited. Furthermore, research exploring the extended-duration consistency of measurements beyond a few cycles, or in women whose cycle length varies significantly month-to-month, data are still emerging.

Evidence for use in Tracking Menstrual Cycle Health

Ovuclon was evaluated in studies examining its application beyond fertility prediction, focusing on outcomes related to systemic or functional imbalance and overall cycle patterns. Research examined the data generated by the device used in observational settings evaluating daily-life functioning, particularly how it captures the natural variations in a woman’s cycle length and phase durations.

Long-term Studies and Follow-up

Research exploring the effects of using Ovuclon continuously over long periods is ongoing. The available long-term data show patterns related to the measurements obtained when the device was observed in studies used repeatedly. Nevertheless, long-term effects are not fully established, and certainty remains low regarding the durability of its measurement consistency beyond twelve cycles.

What is still uncertain about Ovuclon

This section synthesizes the areas where the evidence base is limited or where further research is ongoing. Findings indicate that the greatest uncertainties relate to long-term use and the consistency of research findings in special populations where cycle variations are substantial. The evidence quality varies across studies, and while some findings describe group patterns, research does not determine whether an individual will respond similarly. Studies help show what has been observed so far, but it is important to understand that the study results reflect the specific conditions under which they were conducted.

Frequently Asked Questions (FAQ)

Common questions about Ovuclon (FAQ)


Q: Does Ovuclon interact with over-the-counter pain relievers like ibuprofen?

Official product documents do not typically report specific interactions with common over-the-counter pain relievers, such as ibuprofen. However, regulatory guidance consistently advises discussing all co-administered prescription and non-prescription products with a healthcare provider.

Q: What kind of studies support the use of Ovuclon?

Studies and official information indicate that the drug's use is supported for treating ovulatory dysfunction in women who are seeking to become pregnant. Clinical trial data shows that the medicine is successful in inducing ovulation in a notable percentage of treated patients.

Q: What is the typical timeframe for a treatment cycle with Ovuclon?

According to official product information, a single course of treatment typically involves taking the tablet once daily for five consecutive days. The overall length of therapy is generally restricted to a maximum of about six cycles in total.

Q: What is the risk of multiple pregnancies with Ovuclon, according to research?

Official drug information and studies indicate that there is a minimal chance of multiple pregnancies associated with its use. This topic is routinely addressed within the context of receiving prescription medication.

Q: What are the signs that Ovuclon is starting to work?

The primary physiological response that indicates the medicine is working is ovulation, which generally occurs 5 to 10 days after completing a course of therapy. Appropriate medical monitoring, such as ultrasound or other tests, is typically used by healthcare providers to help determine the exact timing of this event.

Q: Can Ovuclon affect mood or cause emotional changes?

Yes, emotional changes have been reported. Side effects documented in official labeling include depression, and post-marketing reports have also noted changes in mood, anxiety, and irritability.

Q: How does Ovuclon affect the lining of the uterus?

The medicine is known to interact with estrogen-receptor-containing tissues throughout the body, including the endometrium (the lining of the uterus). This action has been noted in authoritative literature to potentially be associated with a reduction in endometrial thickness.

Q: Can Ovuclon be taken with herbal remedies?

Official product information advises caution regarding certain herbal supplements. Specifically, those that may possess hormonal or anti-estrogenic activity should be discussed with a healthcare provider, as combining them could potentially alter the drug's therapeutic effect.

Q: Do I need a special diet while taking Ovuclon?

Official regulatory documents do not mandate a special diet for all patients using this medicine. However, patients who have a pre-existing or family history of high blood fats (hyperlipidemia) are advised to monitor their plasma triglyceride levels due to a reported risk.

Q: Is it common to have light spotting after starting Ovuclon?

Official side effect listings include reports of abnormal uterine bleeding or bleeding between periods, which can include light spotting. The appearance of unexpected or severe bleeding is an important safety consideration noted in product information.

Q: How quickly does Ovuclon start to affect my cycle?

The expected physiological response that indicates the medicine is taking effect—ovulation—generally occurs 5 to 10 days after completing the five-day course of therapy.

Q: Is Ovuclon safe for women who are close to menopause?

The medicine is officially indicated for adult women who are specifically trying to become pregnant. Its safety and effectiveness have not been established for use in older, geriatric patients, and it is typically not used in women whose ovarian function is significantly diminished.

Q: Can Ovuclon be used for conditions other than what is listed in the main uses?

Official product labeling specifies that the medicine is indicated solely for the treatment of ovulatory dysfunction in women desiring pregnancy. The indication is strictly limited to this approved therapeutic purpose.

Q: Are there any specific vitamins or supplements that are not recommended with Ovuclon?

Regulatory documents do not report specific drug-drug interactions with common vitamins. However, any supplement that has hormonal or anti-estrogenic activity, including certain herbals, should be discussed with a healthcare provider before use.

Q: Is fatigue a common side effect when using Ovuclon?

Fatigue is listed among the side effects that have been reported with the use of this medicine. Fatigue, if experienced, is typically addressed through communication with the prescribing healthcare provider.

Q: Will Ovuclon definitely cause me to ovulate?

The medicine is intended to promote ovulation, but it does not guarantee it will occur in every cycle. Authoritative literature from clinical trials indicates that ovulation occurs in a percentage of treated patients, with reported rates generally in the range of 60% to 85%.

Q: Can men use Ovuclon for any purpose?

Official regulatory labeling explicitly indicates the drug is for use only in adult women who are trying to become pregnant and have documented ovulatory dysfunction. Its safety and effectiveness for use in males are not established in official product information.

Q: Are there any foods or drinks that should be avoided when using Ovuclon?

Official product information advises caution when consuming alcoholic drinks during treatment. This is because alcohol consumption may increase the risk of certain side effects such as dizziness or fainting spells. Specific foods are not listed as being universally avoided in the regulatory documentation.

Q: Does Ovuclon work immediately or does it require multiple cycles?

The therapy is typically conducted over a series of treatment courses or cycles, as the desired effect (pregnancy) may not be achieved in the first month. Regulatory guidelines generally recommend limiting treatment to a maximum of about six courses in total.

Q: Are there any long-term effects of using Ovuclon for several cycles?

Official warnings note that prolonged use, such as for one year or more, is associated with an increased risk of ovarian cancer. Due to this safety consideration, regulatory guidelines generally recommend limiting treatment to a total of approximately six cycles.

Q: Can Ovuclon interfere with sleep?

Insomnia, which is difficulty falling or staying asleep, has been documented among the uncommon side effects associated with the medicine. This is a temporary effect noted in the official safety profile.

Q: How is Ovuclon usually packaged?

The medicine is typically supplied as tablets in blister packs, which are manufactured from specific PVC and aluminum foil materials. These strips are then packaged in varying counts within an outer carton.

Q: Can Ovuclon affect the results of other blood tests?

Yes, due to its mechanism of action, the medicine is known to influence the blood levels of certain reproductive hormones, such as FSH and LH. Additionally, monitoring of plasma triglycerides may be recommended for certain patients.

Q: What is the success rate of Ovuclon in clinical trials?

Clinical trials indicate that ovulation rates are generally reported in the range of 60% to 85% among treated patients. Successful therapy, resulting in pregnancy, occurred in approximately 30% of patients evaluated across the trials.

Q: If I have polycystic ovary syndrome (PCOS), is Ovuclon suitable?

Official information and authoritative guidelines note that patients with Polycystic Ovary Syndrome (PCOS) are among those most likely to achieve a successful response with this therapy. The specific eligibility and appropriateness for this therapy is determined through a medical assessment.

Q: Can I drink alcohol while using Ovuclon?

Caution is advised when consuming alcoholic drinks during treatment. This is because alcohol consumption may increase the risk of certain side effects such as dizziness or fainting spells.

Q: What type of monitoring is usually done while a patient is on Ovuclon?

Official product information requires a pelvic examination before the first and each subsequent course of treatment. Other monitoring methods, such as ultrasonographic monitoring or basal body temperature charting, are often used to confirm the timing of ovulation.

Q: Is Ovuclon known to cause headaches?

Headache is listed among the common adverse reactions reported with the use of the medicine in official safety documentation.

Q: If I am vegetarian, does Ovuclon contain animal products?

The list of excipients (inactive ingredients) found in the tablet includes lactose, which is derived from milk.

Q: Are there known drug-drug interactions with common antidepressants?

Official product information advises caution in patients taking antidepressants, particularly those that may affect serotonin levels. This is due to the potential for compounded effects that could influence prolactin levels and ovulation induction.

Q: Does Ovuclon change the timing or flow of a period?

The drug's intended purpose is to induce ovulation, which adjusts the cycle timing. Additionally, the side effect profile includes reports of abnormal uterine bleeding or heavy menstrual periods.

Q: Is Ovuclon used in combination with hCG injections?

The medicine may be used in combination with hCG injections (human chorionic gonadotropins) in certain clinical protocols. This combination is sometimes used to help prompt ovulation.

How should Ovuclon be stored and disposed of?

How to Store and Dispose of Ovuclon (Clomiphene Citrate)

Storage Requirements

Ovuclon tablets must be stored at controlled room temperature, typically between 15 C and 30 C (59 F and 86 F), depending on the regional label. It is mandatory to store the medicine in its original container and to protect it from heat, light, and excessive humidity. The product must be kept out of the sight and reach of children to prevent accidental ingestion.


Disposal Instructions

To ensure proper pharmaceutical waste handling, unused or expired Ovuclon must not be discarded in household rubbish or flushed down the toilet. The product should be returned to a pharmacy or an authorized local collection point for safe disposal in accordance with local regulations.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Ovuclon found in:

A-Z Index: